Skip to main navigation Skip to search Skip to main content

Anti-Laminin-332-schleimhautpemphigoid mit laryngealer beteiligung-adjuvante behandlung mit immunadsorption und rituximab

Translated title of the contribution: Anti-laminin 332 mucous membrane pemphigoid with laryngeal involvement-adjuvant treatment with immunoadsorption and rituximab

Rainer Hügel*, Alois Lang, Karl Lhotta, Wolfgang Elsässer, Johannes Gächter, Elisabeth M. Messmer, Enno Schmidt

*Corresponding author for this work
Translated title of the contributionAnti-laminin 332 mucous membrane pemphigoid with laryngeal involvement-adjuvant treatment with immunoadsorption and rituximab
Original languageGerman
JournalJDDG - Journal of the German Society of Dermatology
Volume16
Issue number7
Pages (from-to)897-900
Number of pages4
ISSN1610-0379
DOIs
Publication statusPublished - 07.2018

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Research Areas and Centers

  • Academic Focus: Center for Infection and Inflammation Research (ZIEL)

Cite this